OSU 03012: Clinical Trials

1 trial of OSU 03012, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow OSU 03012: new trials by email Literature Review of OSU 03012 trials Research Report on OSU 03012

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma
AR-12: (2-Amino-N-[4-[5-(2 phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] phenyl]-acetamide) - Solid Tumors, Lymphoma
Phase 1CompletedArno Therapeutics352009-08-012014-01-29

Conditions studied

Lymphoma (1)

Sponsors

Arno Therapeutics (1)

Countries

United Kingdom (1)  ·  United States (1)

Top investigators

James P Thomas, MD PhD (1)  ·  Johann S de Bono, MD PhD (1)  ·  Raoul Tibes, MD PhD (1)